223 related articles for article (PubMed ID: 10841514)
1. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene.
Eddahibi S; Hanoun N; Lanfumey L; Lesch KP; Raffestin B; Hamon M; Adnot S
J Clin Invest; 2000 Jun; 105(11):1555-62. PubMed ID: 10841514
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension.
MacLean MR; Deuchar GA; Hicks MN; Morecroft I; Shen S; Sheward J; Colston J; Loughlin L; Nilsen M; Dempsie Y; Harmar A
Circulation; 2004 May; 109(17):2150-5. PubMed ID: 15078799
[TBL] [Abstract][Full Text] [Related]
3. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin.
Eddahibi S; Fabre V; Boni C; Martres MP; Raffestin B; Hamon M; Adnot S
Circ Res; 1999 Feb; 84(3):329-36. PubMed ID: 10024307
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.
Guignabert C; Izikki M; Tu LI; Li Z; Zadigue P; Barlier-Mur AM; Hanoun N; Rodman D; Hamon M; Adnot S; Eddahibi S
Circ Res; 2006 May; 98(10):1323-30. PubMed ID: 16614302
[TBL] [Abstract][Full Text] [Related]
5. Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats.
Eddahibi S; Adnot S; Frisdal E; Levame M; Hamon M; Raffestin B
J Pharmacol Exp Ther; 2001 Apr; 297(1):148-54. PubMed ID: 11259539
[TBL] [Abstract][Full Text] [Related]
6. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension.
Marcos E; Fadel E; Sanchez O; Humbert M; Dartevelle P; Simonneau G; Hamon M; Adnot S; Eddahibi S
Circ Res; 2004 May; 94(9):1263-70. PubMed ID: 15059929
[TBL] [Abstract][Full Text] [Related]
7. Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?
Eddahibi S; Raffestin B; Hamon M; Adnot S
J Lab Clin Med; 2002 Apr; 139(4):194-201. PubMed ID: 12024106
[TBL] [Abstract][Full Text] [Related]
8. Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.
Marcos E; Adnot S; Pham MH; Nosjean A; Raffestin B; Hamon M; Eddahibi S
Am J Respir Crit Care Med; 2003 Aug; 168(4):487-93. PubMed ID: 12773327
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease.
Eddahibi S; Chaouat A; Morrell N; Fadel E; Fuhrman C; Bugnet AS; Dartevelle P; Housset B; Hamon M; Weitzenblum E; Adnot S
Circulation; 2003 Oct; 108(15):1839-44. PubMed ID: 14530202
[TBL] [Abstract][Full Text] [Related]
10. A role for the serotonin transporter in hypoxia-induced pulmonary hypertension.
Fanburg BL; Lee SL
J Clin Invest; 2000 Jun; 105(11):1521-3. PubMed ID: 10841509
[No Abstract] [Full Text] [Related]
11. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.
Eddahibi S; Humbert M; Fadel E; Raffestin B; Darmon M; Capron F; Simonneau G; Dartevelle P; Hamon M; Adnot S
J Clin Invest; 2001 Oct; 108(8):1141-50. PubMed ID: 11602621
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice.
Abid S; Houssaini A; Chevarin C; Marcos E; Tissot CM; Gary-Bobo G; Wan F; Mouraret N; Amsellem V; Dubois-Randé JL; Hamon M; Adnot S
Am J Physiol Lung Cell Mol Physiol; 2012 Sep; 303(6):L500-8. PubMed ID: 22797248
[TBL] [Abstract][Full Text] [Related]
13. (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter.
Ni W; Wilhelm CS; Bader M; Murphy DL; Lookingland K; Watts SW
J Pharmacol Exp Ther; 2005 Sep; 314(3):953-60. PubMed ID: 15901794
[TBL] [Abstract][Full Text] [Related]
14. Proliferation and signaling in fibroblasts: role of 5-hydroxytryptamine2A receptor and transporter.
Welsh DJ; Harnett M; MacLean M; Peacock AJ
Am J Respir Crit Care Med; 2004 Aug; 170(3):252-9. PubMed ID: 15087293
[TBL] [Abstract][Full Text] [Related]
15. Specific uptake of 5-hydroxytryptamine is reduced in lungs from hypoxic pulmonary hypertensive rats.
Jeffery TK; Bryan-Lluka LJ; Wanstall JC
Eur J Pharmacol; 2000 May; 396(2-3):137-40. PubMed ID: 10822067
[TBL] [Abstract][Full Text] [Related]
16. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.
Bengel D; Murphy DL; Andrews AM; Wichems CH; Feltner D; Heils A; Mössner R; Westphal H; Lesch KP
Mol Pharmacol; 1998 Apr; 53(4):649-55. PubMed ID: 9547354
[TBL] [Abstract][Full Text] [Related]
17. The serotonin receptor and transporter as potential therapeutic targets for pulmonary hypertension.
Wang HL
Curr Opin Investig Drugs; 2004 Sep; 5(9):963-6. PubMed ID: 15503652
[TBL] [Abstract][Full Text] [Related]
18. Serotonin transporter and serotonin receptors.
Adnot S; Houssaini A; Abid S; Marcos E; Amsellem V
Handb Exp Pharmacol; 2013; 218():365-80. PubMed ID: 24092348
[TBL] [Abstract][Full Text] [Related]
19. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
[TBL] [Abstract][Full Text] [Related]
20. Reduced aggression in mice lacking the serotonin transporter.
Holmes A; Murphy DL; Crawley JN
Psychopharmacology (Berl); 2002 May; 161(2):160-7. PubMed ID: 11981596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
